TNF and neoplasm: In line with this clinical assessment, we found that the enhanced necrotic area of ILP‐TNF/Mel/SM‐treated tumours correlated with improved long‐term local disease control, when compared to standard‐of‐care ILP‐TNF/Mel (in our neoadjuvant protocol).